Skip to content

Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study

Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01120977
Enrollment
150
Registered
2010-05-11
Start date
2010-05-31
Completion date
2011-08-31
Last updated
2011-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth Hormone Deficiency

Brief summary

The treatment of Growth Hormone deficiency (GHD) patients with GH, often induce fluid retention; this effect is dose dependent and temporary. The symptoms are swelling of soft tissue and joint stiffness. The objective of this study is to create bioelectric impedance/arm muscle area (BIA/AMA) reference data, as a measurement of hydration status, of healthy persons of both genders in the age 20-70 years.

Detailed description

The treatment of Growth Hormone deficiency (GHD) patients with GH, has since 1994 been approved in several countries. The approval is based on studies that show positive effect on body composition, physiology, lipid profile, bone density and life quality. One often observed side effect is fluid retention; this effect is dose dependent and temporary. The symptoms are swelling of soft tissue and joint stiffness. By comparing the body bioelectric impedance (BIA) with an Arm Muscle Area (AMA) measurement, it is possible to determine the hydrations status of a person. This measurement is a simple and non invasive method to evaluate the GH dosages applied in the treatment of GHD persons. The objective of this study is to create BIA/AMA reference data of healthy persons of both genders in the age 20-70 years.

Interventions

None listed

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy persons, * Age 20- 70 years.

Exclusion criteria

* Cardiac implanter (pacemaker), * Heart insufficiency, chronic venuos insufficiency, * Use of diuretics, desmopressin, neuroleptica, antidepressants, corticosteroids, fludrocotidon, * Obesity (BMI \> 30), * Knowledge of changes in electrolyte or water homeostasis.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026